Heinz Hammerlindl • UCSF Profiles (original) (raw)

  1. Programmable microparticles rewire CAR signaling to enable super-physiological expansion of human T cells in vitro. bioRxiv. 2025 Jul 22. Zeng Q, Flemming L, Chen Y, Mazumder T, Hammerlindl H, Allen GM, Almeida R, Williams JZ, Hernández-López RA, Eyquem J, Ye CJ, Lim WA, Tang Q, Desai TA, Huang X. PMID: 40777491; PMCID: PMC12330703.
    View in: PubMed Mentions:
  2. Transitive prediction of small-molecule function through alignment of high-content screening resources. Nat Biotechnol. 2025 Jul 11. Bao F, Li L, Hammerlindl H, Shen SQ, Hammerlindl S, Altschuler SJ, Wu LF. PMID: 40646169; PMCID: PMC12846546.
    View in: PubMed Mentions: 1 Fields:
  3. A phenopushing platform to identify compounds that alleviate acute hypoxic stress by fast-tracking cellular adaptation. Nat Commun. 2025 Mar 18; 16(1):2684. Li L, Hammerlindl H, Shen SQ, Bao F, Hammerlindl S, Altschuler SJ, Wu LF. PMID: 40102413; PMCID: PMC11920246.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansAnimalsCells
  4. Implantation of engineered adipocytes suppresses tumor progression in cancer models. Nat Biotechnol. 2025 Dec; 43(12):1979-1995. Nguyen HP, An K, Ito Y, Kharbikar BN, Sheng R, Paredes B, Murray E, Pham K, Bruck M, Zhou X, Biellak C, Ushiki A, Nobuhara M, Fong SL, Bernards DA, Lynce F, Dillon DA, Magbanua MJM, Huppert LA, Hammerlindl H, Klein JA, Valdiviez L, Fiehn O, Esserman L, Desai TA, Yee SW, Rosenbluth JM, Ahituv N. PMID: 39905264; PMCID: PMC12319119.
    View in: PubMed Mentions: 20 Fields:
    Translation:HumansAnimalsCells
  5. Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance. Pharmacol Res. 2024 Sep; 207:107298. Benfield AH, Vernen F, Young RSE, Nadal-Bufí F, Lamb H, Hammerlindl H, Craik DJ, Schaider H, Lawrence N, Blanksby SJ, Henriques ST. PMID: 39032840.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansAnimalsCells
  6. Small molecule in situ resin capture provides a compound first approach to natural product discovery. Nat Commun. 2024 Jun 19; 15(1):5230. Bogdanov A, Salib MN, Chase AB, Hammerlindl H, Muskat MN, Luedtke S, da Silva EB, O'Donoghue AJ, Wu LF, Altschuler SJ, Molinski TF, Jensen PR. PMID: 38898025; PMCID: PMC11187115.
    View in: PubMed Mentions: 6 Fields:
  7. H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resist Updat. 2023 11; 71:100993. Ravindran Menon D, Hammerlindl H, Gimenez G, Hammerlindl S, Zuegner E, Torrano J, Bordag N, Emran AA, Giam M, Denil S, Pavelka N, Tan AC, Sturm RA, Haass NK, Rancati G, Herlyn M, Magnes C, Eccles MR, Fujita M, Schaider H. PMID: 37639774; PMCID: PMC10719180.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansCells
  8. Small Molecule in situ Resin Capture - A Compound First Approach to Natural Product Discovery. bioRxiv. 2023 May 30. Bogdanov A, Salib MN, Chase AB, Hammerlindl H, Muskat MN, Luedtke S, Barbosa da Silva E, O'Donoghue AJ, Wu LF, Altschuler SJ, Molinski TF, Jensen PR. PMID: 37398257; PMCID: PMC10312467.
    View in: PubMed Mentions:
  9. Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progression. bioRxiv. 2023 Mar 29. Nguyen HP, Sheng R, Murray E, Ito Y, Bruck M, Biellak C, An K, Lynce F, Dillon DA, Magbanua MJM, Huppert LA, Hammerlindl H, Esserman L, Rosenbluth JM, Ahituv N. PMID: 37034710; PMCID: PMC10081280.
    View in: PubMed Mentions:
  10. View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  11. Differential toxicity to murine small and large intestinal epithelium induced by oncology drugs. Commun Biol. 2022 01 27; 5(1):99. Bieber JM, Sanman LE, Sun X, Hammerlindl H, Bao F, Roth MA, Koleske ML, Huang L, Aweeka F, Wu LF, Altschuler SJ. PMID: 35087225; PMCID: PMC8795448.
    View in: PubMed Mentions: 3 Translation:AnimalsCells
  12. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics. 2020; 10(14):6261-6277. Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. PMID: 32483452; PMCID: PMC7255038.
    View in: PubMed Mentions: 29 Fields:
    Translation:HumansAnimalsCells
  13. Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics. 2019 05; 11(7):732-737. Emran AA, Marzese DM, Menon DR, Hammerlindl H, Ahmed F, Richtig E, Duijf P, Hoon DS, Schaider H. PMID: 31070054; PMCID: PMC6595545.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansCells
  14. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. Clin Epigenetics. 2019 03 08; 11(1):43. Torrano J, Al Emran A, Hammerlindl H, Schaider H. PMID: 30850015; PMCID: PMC6408861.
    View in: PubMed Mentions: 43 Fields:
    Translation:HumansAnimalsCells
  15. Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma. Cancer Med. 2019 03; 8(3):1186-1196. Emran AA, Chinna Chowdary BR, Ahmed F, Hammerlindl H, Huefner A, Haass NK, Schuehly W, Schaider H. PMID: 30793515; PMCID: PMC6434221.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansCells
  16. Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget. 2018 Feb 02; 9(9):8206-8222. Emran AA, Marzese DM, Menon DR, Stark MS, Torrano J, Hammerlindl H, Zhang G, Brafford P, Salomon MP, Nelson N, Hammerlindl S, Gupta D, Mills GB, Lu Y, Sturm RA, Flaherty K, Hoon DSB, Gabrielli B, Herlyn M, Schaider H. PMID: 29492189; PMCID: PMC5823586.
    View in: PubMed Mentions: 46 Fields:
  17. Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant Cancers. Clin Cancer Res. 2018 03 01; 24(5):1090-1102. Hammerlindl H, Ravindran Menon D, Hammerlindl S, Emran AA, Torrano J, Sproesser K, Thakkar D, Xiao M, Atkinson VG, Gabrielli B, Haass NK, Herlyn M, Krepler C, Schaider H. PMID: 29196297; PMCID: PMC5844814.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansAnimalsCells
  18. Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance. J Cell Commun Signal. 2018 Mar; 12(1):133-141. Hammerlindl H, Schaider H. PMID: 29192388; PMCID: PMC5842196.
    View in: PubMed Mentions: 33
  19. Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors. Cancer Res. 2016 04 01; 76(7):1690-7. Bonyadi Rad E, Hammerlindl H, Wels C, Popper U, Ravindran Menon D, Breiteneder H, Kitzwoegerer M, Hafner C, Herlyn M, Bergler H, Schaider H. PMID: 26801977; PMCID: PMC5167360.
    View in: PubMed Mentions: 36 Fields:
    Translation:HumansCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs